Elevated plasma levels of the kidney marker KIM-1, the liver marker α-GST, and the kidney and liver marker FABP-1 in AIP cases suggest proximal tubular kidney damage and hepatocellular damage. This evidence concerns the gene HAVCR1 and autoimmune pancreatitis.